Lack of Prognostic Significance of BCL2 and p53 Protein Overexpression in Elderly Patients with Diffuse Large B-cell Non-Hodgkin's Lymphoma: Results from a Population-based Non-Hodgkin's Lymphoma Registry

References

• The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) "A preditive model for aggressive non-Hodgkin's lymphoma", New England Journal of Medicine, 329, 987–994.
   PubMed Web of Science ®Google Scholar
• Gaiter, K.C. and Warnke, R.A. (2001) Diffuse large B-cell lymphoma. In Tumours of Haematopoietic and Lymphoid tissues: Pathology & Genetics. WHO Classification of Tumours, edited by E.S. Jaffe, N.L. Harris, H. Stein and J.W. Vardiman. Pp. 171 — 174. Lyon. IARC Press.
   Google Scholar
• Winter, J.N. (1999) "Prognostic indicators in diffuse, aggressive non-Hodgkin's lymphomas: regulators of growth fraction and pro-grammed cell death", Seminars in Oncology, 26\(suppl 14), 26–33.
   PubMed Web of Science ®Google Scholar
• Gascoyne, R.D. (1997) "Pathologic prognostic factors in diffuse aggressive non-Hodgkin's lymphoma", Hematology/Oncology Clinics of North America, 11, 847–862.
   PubMed Web of Science ®Google Scholar
• Alizadeh, A.A., Eisen, M.B., Davis, E.R., Ma, C., Lossos, IS., Rosenwald, A., et al. (2000) "Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling", Nature, 403, 503— 511.
   Google Scholar
• Shipp, M.A., Ross, K.N., Tamayo, P., Weng, A.P., Kutok, J.L., Aguiar, R.C.T., et al. (2002) "Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning", Nature Medicine, 8, 68–74.
   Google Scholar
• Rosenwald, A., Wright, G., Chan, W.C., Connors, J.M., Campo, E., Fisher, RI., et al. (2002) "The use of molecular profiling to predict survial after chemotherapy for diffuse large B-cell lympho-ma", New England Journal of Medicine, 346, 1937–1947.
   Web of Science ®Google Scholar
• The Non-Hodgkin's Lymphoma Classification Project (1997) "Effect of age on the characteristics and clinical behavior of non-Hodgkin's lymphoma patients", Annals of Oncology, 8, 973–978.
   Google Scholar
• Maartense, E., Kluin-Nelemans, J.C., Cessie le, S., Kluin, Ph. M., Snijder, S. and Noordijk, E.M. (2000) "Different age limits for elderly patients with indolent and aggressive non-Hodgkin's lymphoma and the role of relative survival with rising age: analysis of a population-based non-Hodgkin's lymphoma registry", Cancer, 89, 2667–2676.
   Web of Science ®Google Scholar
• Kramer, M.H.H., Hermans, J., Parker, J., Krol, A.D.G., Kluin-Nelemans, J.C., Haak, H.L., et al. (1996) "Clinical significance of bc12 and p53 protein expression in diffuse large B-cell lymphoma; a population-based study", Journal of Clinical Oncology, 14, 2131 — 2138.
   Web of Science ®Google Scholar
• Kramer, M.H.H., Hermans, J., Wijburg, E., Philipp°, K., Krieken van, J.H.J.M., Jong de, J., et al. (1998) "Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma", Blood, 9, 3152–3162.
   PubMed Web of Science ®Google Scholar
• Maartense, E., Hermans, J., Kluin-Nelemans, J.C., Kluin, Ph. M., Deijk van, W.A., Snijder, S., et al. (1998) "Elderly patients with non-Hodgkin's lymphoma: population-based results in the Nether-lands", Annals of Oncology, 9, 1219 — 1227.
   Google Scholar
• Maartense, E., Cessie le, S., Kluin-Nelemans, J.C., Kluin, Ph. M., Snijder, S., Wijermans, P.W. et al. (2002) "Age related differences among patients with follicular lymphoma and the importance of prognostic scoring systems: analysis from a population-based non-Hodgkin's lymphoma registry", Annals of Oncology, 13, 1275 — 1284.
   Google Scholar
• Harris, N.L., Jaffe, ES., Stein, H., Banks, P.M., Chan, J.K.C., Cleary, M.L., et al. (1994) "A revised European—American Classification of lymphoid neoplasms; a proposal from the International Lymphoma Study Group", Blood, 84, 1361–1392.
   Google Scholar
• Barrans, S.L., Carter, I., Owen, R.G., Davies, F.E., Patmore, R.D., Haynes, A.P., et al. (2002) "Germinal center phenotype and bc1-2 expression combined with the International Prognostic Index improves patients risk stratification in diffuse large B-cell lympho-ma", Blood, 99, 1136 — 1143.
   Google Scholar
• Hermine, O., Haioun, C., Lepage, E., d'Agay, M.F., Briere, J., Lavignac, C., et al. (1996) "Prognostic significance of bc1-2 protein expression in aggressive non-Hodgkin's lymphoma", Blood, 87, 265— 272.
   Google Scholar
• Hill, M.E., MacLennan, K.A., Cunningham, D.C., Vaughan Hudson, B., Burke, M., Clarke, P., et al. (1996) "Prognostic significance of BCL-2 expression and bc1-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma investigation study", Blood, 88, 1046 — 1051.
   Google Scholar
• Gascoyne, R.D., Adomat, S.A., Krajewski, S., Krajewska, M., Horsman, D.E., Tolcher, A.W., et al. (1997) "Prognostic signifi-cance of Bc1-2 protein expression and Bc1-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma", Blood, 90, 244 — 251.
   Google Scholar
• Wilson, W.H., Teruya-Feldstein, J., Fest, T., Harris, C., Steinberg, S.M., Jaffe, ES., et al. (1997) "Relationship of p53, bc1-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas", Blood, 89, 601–609.
   PubMed Web of Science ®Google Scholar
• Sanchez, E., Chacon, I., Plaza, M.M., Munoz, E., Cruz, M.A., Martinez, B., et al. (1998) "Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins", Journal of Clinical Oncology, 16, 1931 — 1939.
   Google Scholar
• Pins, M.A., Pezella, F., Martinez-Montero, J.C., Orradre, J.L., Villuendas, R., Sanchez-Beato, M., et al. (1994) "P53 and bc1-2 expression in high-grade B-cell lymphomas: correlation with survival time", British Journal of Cancer, 69, 337–341.
   PubMed Web of Science ®Google Scholar
• Ichikawa, A., Kinoshita, T., Watanabe, T., Kato, H., Nagai, H., Tsushita, K., et al. (1997) "Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma", New England Journal of Medicine, 337, 529–534.
   PubMed Web of Science ®Google Scholar
• Moller, M.B., Gerdes, A.M., Skjodt, K., Mortensen, L.S. and Pedersen, N.T. (1999) "Disrupted p53 function as predictor of treatment failure and poor prognosis in B- and T-cell non-Hodgkin's lymphoma", Clinical Cancer Research, 5, 1085 — 1091.
   PubMed Web of Science ®Google Scholar
• Leroy, K., Haioun, C., Lepage, E., Métayer le, N., Berger, F., Labouyrie, E., et al. (2002) "P53 gene mutations are associated with poor survival in low and low-intermediate risk diffuse large B-cell lymphomas", Annals of Oncology, 13, 1108 — 1115.
   Google Scholar